DalsnaFinance

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Markets GlobeNewswire By GlobeNewswire 01 Jun 2026 12:30 1 min read
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

If approved, D-PLEX100 would address a critical unmet medical need in the prevention of surgical site infections

If approved, D-PLEX100 would address a critical unmet medical need in the prevention of surgical site infections

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.